[EN] PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE LA PIPÉRIDINONE EN TANT QU'INHIBITEURS DE MDM2 POUR LE TRAITEMENT DU CANCER
申请人:AMGEN INC
公开号:WO2011153509A1
公开(公告)日:2011-12-08
The present invention provides MDM2 inhibitor compounds of Formula (I), wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
Copper-Catalyzed Enantioselective Conjugate Addition of Grignard Reagents to Acyclic Enones
作者:Fernando López、Syuzanna R. Harutyunyan、Adriaan J. Minnaard、Ben L. Feringa
DOI:10.1021/ja046632t
日期:2004.10.1
A highly enantioselective Cu-catalyzed addition of Grignard reagents to acyclic aliphatic enones is described. In the presence of 5 mol % of CuBr.SMe2 and 6 mol % of JosiPhos diphosphine aliphatic enones react with Grignard reagents to provide beta-substituted linear ketones with high yields, regio-, and enantioselectivities.
CHIRAL BINUCLEAR METAL COMPLEXES FOR STEREOSELECTIVE GLYCOSIDE HYDROLYSIS OF SACCHARIDES
申请人:BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
公开号:US20170275303A1
公开(公告)日:2017-09-28
Disclosed herein is a class of chiral binuclear metal complexes for stereoselective glycoside hydrolysis of saccharides, and more particular chiral binuclear transition metal complex catalysts that discriminate epimeric glycosides and α- and β-glycosidic bonds of saccharides in aqueous solutions at near physiological pHs. The chiral binuclear metal complexes include a Schiff-base-type ligand derived from a chiral diamino building block, and a binuclear transition metal core, each which can be varied for selectivity. The metal core is a Lewis-acidic metal ion, such as copper, zinc, lanthanum, iron and nickel. The Schiff-base may be a reduced or non-reduced Schiff-base derived from aliphatic linear, aliphatic cyclic diamino alcohols or aromatic aldehydes. The ligand can be a penta- or heptadentate ligand derived from pyridinecarbaldehydes, benzaldehydes, linear or cyclic diamines or diamino alcohols.
ESTER ENOLATE CLAISEN REARRANGEMENT OF 2-BUTENYL 3-HYDROXYBUTANOATE
作者:Tamotsu Fujisawa、Kazuhisa Tajima、Masamichi Ito、Toshio Sato
DOI:10.1246/cl.1984.1169
日期:1984.7.5
The ester enolateClaisenrearrangement of (E)- or (Z)-2-butenyl 3-hydroxybutanoate was found to give predominantly each one of four isomers of 3-methyl-4-methoxycarbonyl-5-hydroxy-1-hexene by the selection of the reaction conditions via the enolate dianions or silyl ketene acetals.
Substituted Heterocyclic Derivative, Preparation Method And Use Thereof
申请人:Xiamen University
公开号:US20170334896A1
公开(公告)日:2017-11-23
The invention provides a compound as shown by Formula I having an enzyme activity which can inhibit endocannabinoid hydrolases NAAA and/or FAAH, or a pharmaceutically acceptable salt, hydrate or solvate thereof, and a preparation method and a use of the compound.